# ONO-7436 Phase II Study in Japan

> **NCT00212602** · PHASE2 · COMPLETED · sponsor: **Ono Pharmaceutical Co., Ltd.** · enrollment: 420 (—)

## Conditions studied

- Malignant Tumor

## Interventions

- **DRUG:** ONO-7436

## Key facts

- **NCT ID:** NCT00212602
- **Lead sponsor:** Ono Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-08
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 420 (—)
- **Last updated:** 2012-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00212602

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00212602, "ONO-7436 Phase II Study in Japan". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00212602. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*